TY - JOUR AU - Rynes, R. I. PY - 1997 DA - 1997// TI - Antimalarial drugs in the treatment of rheumatological diseases JO - Br J Rheumatol VL - 36 UR - https://doi.org/10.1093/rheumatology/36.7.799 DO - 10.1093/rheumatology/36.7.799 ID - Rynes1997 ER - TY - JOUR AU - MacIntyre, A. C. AU - Cutler, D. J. PY - 1988 DA - 1988// TI - Role of lysosomes in hepatic accumulation of chloroquine JO - J Pharm Sci VL - 77 UR - https://doi.org/10.1002/jps.2600770303 DO - 10.1002/jps.2600770303 ID - MacIntyre1988 ER - TY - JOUR AU - Macfarlane, D. E. AU - Manzel, L. PY - 1998 DA - 1998// TI - Antagonism of immunostimulatory CpG-oligodeoxynucleotides by quinacrine, chloroquine, and structurally related compounds JO - J Immunol VL - 160 ID - Macfarlane1998 ER - TY - JOUR AU - Karres, I. AU - Kremer, J. P. AU - Dietl, I. AU - Steckholzer, U. AU - Jochum, M. AU - Ertel, W. PY - 1998 DA - 1998// TI - Chloroquine inhibits proinflammatory cytokine release into human whole blood JO - Am J Physiol VL - 274 ID - Karres1998 ER - TY - JOUR AU - Seitz, M. AU - Valbracht, J. AU - Quach, J. AU - Lotz, M. PY - 2003 DA - 2003// TI - Gold sodium thiomalate and chloroquine inhibit cytokine production in monocytic THP-1 cells through distinct transcriptional and posttranslational mechanisms JO - J Clin Immunol VL - 23 UR - https://doi.org/10.1023/B:JOCI.0000010424.41475.17 DO - 10.1023/B:JOCI.0000010424.41475.17 ID - Seitz2003 ER - TY - JOUR AU - Zhu, X. AU - Ertel, W. AU - Ayala, A. AU - Morrison, M. H. AU - Perrin, M. M. AU - Chaudry, I. H. PY - 1993 DA - 1993// TI - Chloroquine inhibits macrophage tumour necrosis factor-alpha mRNA transcription JO - Immunology VL - 80 ID - Zhu1993 ER - TY - JOUR AU - Weber, S. M. AU - Levitz, S. M. PY - 2000 DA - 2000// TI - Chloroquine interferes with lipopolysaccharide-induced TNF-alpha gene expression by a nonlysosomotropic mechanism JO - J Immunol VL - 165 UR - https://doi.org/10.4049/jimmunol.165.3.1534 DO - 10.4049/jimmunol.165.3.1534 ID - Weber2000 ER - TY - JOUR AU - Kroeger, K. M. AU - Steer, J. H. AU - Joyce, D. A. AU - Abraham, L. J. PY - 2000 DA - 2000// TI - Effects of stimulus and cell type on the expression of the -308 tumour necrosis factor promoter polymorphism JO - Cytokine VL - 12 UR - https://doi.org/10.1006/cyto.1999.0529 DO - 10.1006/cyto.1999.0529 ID - Kroeger2000 ER - TY - JOUR AU - Wilson, A. G. AU - Symons, J. A. AU - McDowell, T. L. AU - McDevitt, H. O. AU - Duff, G. W. PY - 1997 DA - 1997// TI - Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation JO - Proc Natl Acad Sci USA VL - 94 UR - https://doi.org/10.1073/pnas.94.7.3195 DO - 10.1073/pnas.94.7.3195 ID - Wilson1997 ER - TY - JOUR AU - Suarez, A. AU - Lopez, P. AU - Mozo, L. AU - Gutierrez, C. PY - 2005 DA - 2005// TI - Differential effect of IL10 and TNF{alpha} genotypes on determining susceptibility to discoid and systemic lupus erythematosus JO - Ann Rheum Dis VL - 64 UR - https://doi.org/10.1136/ard.2004.035048 DO - 10.1136/ard.2004.035048 ID - Suarez2005 ER - TY - JOUR AU - Suarez, A. AU - Castro, P. AU - Alonso, R. AU - Mozo, L. AU - Gutierrez, C. PY - 2003 DA - 2003// TI - Interindividual variations in constitutive interleukin-10 messenger RNA and protein levels and their association with genetic polymorphisms JO - Transplantation VL - 75 UR - https://doi.org/10.1097/01.TP.0000055216.19866.9A DO - 10.1097/01.TP.0000055216.19866.9A ID - Suarez2003 ER - TY - JOUR AU - Turner, D. M. AU - Williams, D. M. AU - Sankaran, D. AU - Lazarus, M. AU - Sinnott, P. J. AU - Hutchinson, I. V. PY - 1997 DA - 1997// TI - An investigation of polymorphism in the interleukin-10 gene promoter JO - Eur J Immunogenet VL - 24 UR - https://doi.org/10.1111/j.1365-2370.1997.tb00001.x DO - 10.1111/j.1365-2370.1997.tb00001.x ID - Turner1997 ER - TY - JOUR AU - Lopez, P. AU - Mozo, L. AU - Gutierrez, C. AU - Suarez, A. PY - 2003 DA - 2003// TI - Epidemiology of systemic lupus erythematosus in a northern Spanish population: gender and age influence on immunological features JO - Lupus VL - 12 UR - https://doi.org/10.1191/0961203303lu469xx DO - 10.1191/0961203303lu469xx ID - Lopez2003 ER - TY - JOUR AU - Tan, E. M. AU - Cohen, A. S. AU - Fries, J. F. AU - Masi, A. T. AU - McShane, D. J. AU - Rothfield, N. F. AU - Schaller, J. G. AU - Talal, N. AU - Winchester, R. J. PY - 1982 DA - 1982// TI - The 1982 revised criteria for the classification of systemic lupus erythematosus JO - Arthritis Rheum VL - 25 UR - https://doi.org/10.1002/art.1780251101 DO - 10.1002/art.1780251101 ID - Tan1982 ER - TY - JOUR AU - Salmeron, G. AU - Lipsky, P. E. PY - 1983 DA - 1983// TI - Immunosuppressive potential of antimalarials JO - Am J Med VL - 75 UR - https://doi.org/10.1016/0002-9343(83)91266-4 DO - 10.1016/0002-9343(83)91266-4 ID - Salmeron1983 ER - TY - JOUR AU - Hong, Z. AU - Jiang, Z. AU - Liangxi, W. AU - Guofu, D. AU - Ping, L. AU - Yongling, L. AU - Wendong, P. AU - Minghai, W. PY - 2004 DA - 2004// TI - Chloroquine protects mice from challenge with CpG ODN and LPS by decreasing proinflammatory cytokine release JO - Int Immunopharmacol VL - 4 UR - https://doi.org/10.1016/j.intimp.2003.12.006 DO - 10.1016/j.intimp.2003.12.006 ID - Hong2004 ER - TY - JOUR AU - Weber, S. M. AU - Chen, J. M. AU - Levitz, S. M. PY - 2002 DA - 2002// TI - Inhibition of mitogen-activated protein kinase signaling by chloroquine JO - J Immunol VL - 168 UR - https://doi.org/10.4049/jimmunol.168.10.5303 DO - 10.4049/jimmunol.168.10.5303 ID - Weber2002 ER - TY - JOUR AU - Hugosson, E. AU - Montgomery, S. M. AU - Premji, Z. AU - Troye-Blomberg, M. AU - Bjorkman, A. PY - 2004 DA - 2004// TI - Higher IL-10 levels are associated with less effective clearance of Plasmodium falciparumparasites JO - Parasite Immunol VL - 26 UR - https://doi.org/10.1111/j.0141-9838.2004.00678.x DO - 10.1111/j.0141-9838.2004.00678.x ID - Hugosson2004 ER - TY - JOUR AU - Aringer, M. AU - Feierl, E. AU - Steiner, G. AU - Stummvoll, G. H. AU - Hofler, E. AU - Steiner, C. W. AU - Radda, I. AU - Smole, J. S. AU - Graninger, W. B. PY - 2002 DA - 2002// TI - Increased bioactive TNF in human systemic lupus erythematosus: associations with cell death JO - Lupus VL - 11 UR - https://doi.org/10.1191/0961203302lu160oa DO - 10.1191/0961203302lu160oa ID - Aringer2002 ER - TY - JOUR AU - Atzeni, F. AU - Sarzi-Puttini, P. AU - Doria, A. AU - Iaccarino, L. AU - Capsoni, F. PY - 2005 DA - 2005// TI - Potential off-label use of infliximab in autoimmune and non-autoimmune diseases: a review JO - Autoimmun Rev VL - 4 UR - https://doi.org/10.1016/j.autrev.2004.08.004 DO - 10.1016/j.autrev.2004.08.004 ID - Atzeni2005 ER - TY - JOUR AU - Rood, M. J. AU - van Krugten, M. V. AU - Zanelli, E. AU - van der Linden, M. W. AU - Keijsers, V. AU - Schreuder, G. M. AU - Verduyn, W. AU - Westendorp, R. G. AU - de Vries, R. R. AU - Breedveld, F. C. AU - Verweij, C. L. AU - Huizinga, T. W. PY - 2000 DA - 2000// TI - TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus JO - Arthritis Rheum VL - 43 UR - https://doi.org/3.0.CO;2-S DO - 3.0.CO;2-S ID - Rood2000 ER - TY - JOUR AU - Sullivan, K. E. AU - Wooten, C. AU - Schmeckpeper, B. J. AU - Goldman, D. AU - Petri, M. A. PY - 1997 DA - 1997// TI - A promoter polymorphism of tumor necrosis factor alpha associated with systemic lupus erythematosus in African-Americans JO - Arthritis Rheum VL - 40 UR - https://doi.org/10.1002/art.1780401215 DO - 10.1002/art.1780401215 ID - Sullivan1997 ER - TY - JOUR AU - Davis, J. C. AU - van der Heijde, D. M. AU - Braun, J. AU - Dougados, M. AU - Cush, J. AU - Clegg, D. AU - Inman, R. D. AU - Kivitz, A. AU - Zhou, L. AU - Solinger, A. AU - Tsuji, W. PY - 2005 DA - 2005// TI - Sustained durability and tolerability of etanercept in ankylosing spondylitis for 96 weeks JO - Ann Rheum Dis VL - 64 UR - https://doi.org/10.1136/ard.2004.035105 DO - 10.1136/ard.2004.035105 ID - Davis2005 ER - TY - JOUR AU - Maini, R. AU - St Clair, E. W. AU - Breedveld, F. AU - Furst, D. AU - Kalden, J. AU - Weisman, M. AU - Smolen, J. AU - Emery, P. AU - Harriman, G. AU - Feldmann, M. AU - Lipsky, P. PY - 1999 DA - 1999// TI - Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group JO - Lancet VL - 354 UR - https://doi.org/10.1016/S0140-6736(99)05246-0 DO - 10.1016/S0140-6736(99)05246-0 ID - Maini1999 ER - TY - JOUR AU - Reimold, A. M. PY - 2003 DA - 2003// TI - New indications for treatment of chronic inflammation by TNF-alpha blockade JO - Am J Med Sci VL - 325 UR - https://doi.org/10.1097/00000441-200302000-00005 DO - 10.1097/00000441-200302000-00005 ID - Reimold2003 ER - TY - JOUR AU - Suryaprasad, A. G. AU - Prindiville, T. PY - 2003 DA - 2003// TI - The biology of TNF blockade JO - Autoimmun Rev VL - 2 UR - https://doi.org/10.1016/S1568-9972(03)00048-X DO - 10.1016/S1568-9972(03)00048-X ID - Suryaprasad2003 ER - TY - JOUR AU - Tutuncu, Z. AU - Kavanaugh, A. AU - Zvaifler, N. AU - Corr, M. AU - Deutsch, R. AU - Boyle, D. PY - 2005 DA - 2005// TI - Fcgamma receptor type IIIA polymorphisms influence treatment outcomes in patients with inflammatory arthritis treated with tumor necrosis factor alpha-blocking agents JO - Arthritis Rheum VL - 52 UR - https://doi.org/10.1002/art.21266 DO - 10.1002/art.21266 ID - Tutuncu2005 ER - TY - JOUR AU - Criswell, L. A. AU - Lum, R. F. AU - Turner, K. N. AU - Woehl, B. AU - Zhu, Y. AU - Wang, J. AU - Tiwari, H. K. AU - Edberg, J. C. AU - Kimberly, R. P. AU - Moreland, L. W. AU - Seldin, M. F. AU - Bridges, S. L. PY - 2004 DA - 2004// TI - The influence of genetic variation in the HLA-DRB1 and LTA-TNF regions on the response to treatment of early rheumatoid arthritis with methotrexate or etanercept JO - Arthritis Rheum VL - 50 UR - https://doi.org/10.1002/art.20469 DO - 10.1002/art.20469 ID - Criswell2004 ER - TY - JOUR AU - Taylor, K. D. AU - Plevy, S. E. AU - Yang, H. AU - Landers, C. J. AU - Barry, M. J. AU - Rotter, J. I. AU - Targan, S. R. PY - 2001 DA - 2001// TI - ANCA pattern and LTA haplotype relationship to clinical responses to anti-TNF antibody treatment in Crohn's disease JO - Gastroenterology VL - 120 UR - https://doi.org/10.1053/gast.2001.23966 DO - 10.1053/gast.2001.23966 ID - Taylor2001 ER - TY - JOUR AU - Mugnier, B. AU - Balandraud, N. AU - Darque, A. AU - Roudier, C. AU - Roudier, J. AU - Reviron, D. PY - 2003 DA - 2003// TI - Polymorphism at position -308 of the tumor necrosis factor alpha gene influences outcome of infliximab therapy in rheumatoid arthritis JO - Arthritis Rheum VL - 48 UR - https://doi.org/10.1002/art.11168 DO - 10.1002/art.11168 ID - Mugnier2003 ER - TY - JOUR AU - Padyukov, L. AU - Lampa, J. AU - Heimburger, M. AU - Ernestam, S. AU - Cederholm, T. AU - Lundkvist, I. AU - Andersson, P. AU - Hermansson, Y. AU - Harju, A. AU - Klareskog, L. AU - Bratt, J. PY - 2003 DA - 2003// TI - Genetic markers for the efficacy of tumour necrosis factor blocking therapy in rheumatoid arthritis JO - Ann Rheum Dis VL - 62 UR - https://doi.org/10.1136/ard.62.6.526 DO - 10.1136/ard.62.6.526 ID - Padyukov2003 ER - TY - JOUR AU - Anolik, J. H. AU - Aringer, M. PY - 2005 DA - 2005// TI - New treatments for SLE: cell-depleting and anti-cytokine therapies JO - Best Pract Res Clin Rheumatol VL - 19 UR - https://doi.org/10.1016/j.berh.2005.05.006 DO - 10.1016/j.berh.2005.05.006 ID - Anolik2005 ER - TY - JOUR AU - Smolen, J. S. AU - Steiner, G. AU - Aringer, M. PY - 2005 DA - 2005// TI - Anti-cytokine therapy in systemic lupus erythematosus JO - Lupus VL - 14 UR - https://doi.org/10.1191/0961203305lu2134oa DO - 10.1191/0961203305lu2134oa ID - Smolen2005 ER - TY - JOUR AU - Aringer, M. AU - Graninger, W. B. AU - Steiner, G. AU - Smolen, J. S. PY - 2004 DA - 2004// TI - Safety and efficacy of tumor necrosis factor alpha blockade in systemic lupus erythematosus: an open-label study JO - Arthritis Rheum VL - 50 UR - https://doi.org/10.1002/art.20576 DO - 10.1002/art.20576 ID - Aringer2004 ER -